Borregaard ASA (OSL:BRG)
Norway
· Delayed Price · Currency is NOK | Market Cap | 19.51B |
| Revenue (ttm) | 7.62B |
| Net Income (ttm) | 823.00M |
| Shares Out | 99.55M |
| EPS (ttm) | 8.25 |
| PE Ratio | 23.76 |
| Forward PE | 19.18 |
| Dividend | 4.25 (2.17%) |
| Ex-Dividend Date | Apr 11, 2025 |
| Volume | 16,452 |
| Average Volume | 78,618 |
| Open | 196.40 |
| Previous Close | 196.60 |
| Day's Range | 193.80 - 197.00 |
| 52-Week Range | 174.20 - 209.50 |
| Beta | 0.52 |
| RSI | 54.34 |
| Earnings Date | Jan 29, 2025 |
About Borregaard ASA
Borregaard ASA engages in the development, production, and marketing of specialized biomaterials and biochemicals in Norway, rest of Europe, the United States, Asia, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment develops, produces, and sells biopolymers for various applications, such as agrochemicals, batteries, industrial binders, and construction; and biovanillin for flavor and fragrance companies, as well as for food and beverage industry. The BioMaterials segment... [Read more]
Financial Performance
In 2024, Borregaard ASA's revenue was 7.62 billion, an increase of 6.80% compared to the previous year's 7.13 billion. Earnings were 823.00 million, a decrease of -5.40%.
Financial StatementsNews
Q4 2024 Borregaard ASA Earnings Call Transcript
Q4 2024 Borregaard ASA Earnings Call Transcript
Borregaard ASA: EBITDA1 of NOK 398 million in the 4th quarter
Borregaard's operating revenues were NOK 1,744 million (NOK 1,605 million)2 in the 4th quarter of 2024. EBITDA1 reached NOK 398 million (NOK 327 million). The result in BioSolutions increased compared...
Borregaard ASA: EBITDA1 of NOK 524 million in the 3rd quarter
Borregaard's operating revenues were NOK 1,949 million (NOK 1,714 million)2 in the 3rd quarter of 2024. EBITDA1 reached NOK 524 million (NOK 482 million). The result in both BioSolutions and Fine Chem...
Borregaard ASA: EBITDA1 of NOK 510 million in the 2nd quarter
Borregaard's operating revenues were NOK 1,949 million (NOK 1,963 million)2 in the 2nd quarter of 2024. EBITDA1 was NOK 510 million (NOK 537 million). The result in BioSolutions increased while the re...
Borregaard ASA: EBITDA1 of NOK 442 million in the 1st quarter
Borregaard's operating revenues reached NOK 1,975 million (NOK 1,850 million)2 in the 1st quarter of 2024. EBITDA1 increased to NOK 442 million (NOK 435 million). The result in BioSolutions increased ...
Borregaard ASA: EBITDA1 of NOK 482 million in the 3rd quarter
Borregaard's operating revenues were NOK 1,714 million (NOK 1,752 million)2 in the 3rd quarter of 2023. EBITDA1 increased to NOK 482 million (NOK 434 million). BioMaterials and Fine Chemicals had resu...
Borregaard ASA: EBITDA1 of NOK 435 million in the 1st quarter
Borregaard's operating revenues increased to NOK 1,850 million (NOK 1,615 million)2. EBITDA1 reached NOK 435 million (NOK 400 million). Fine Chemicals and BioMaterials had result improvements while Bi...
Borregaard ASA: Shares for employees 2023
6 February 2023: Borregaard ASA (“Borregaard”, OSE ticker: BRG)
Borregaard ASA: Reporting of transactions in Borregaard ASA's shares made by person discharging managerial responsibilities
Today, primary insider Gisle Løhre Johansen, Executive Vice President (EVP), exercised 15,000 stock options at a strike price of NOK 70.30 per share and in separate transactions, purchased and sold th...
Borregaard ASA: Reporting of transactions in Borregaard ASA's shares made by person discharging managerial responsibilities and closely related parties
Today, Sveinung Heggen, General Counsel, exercised 13,700 stock options at a strike price of NOK 65.95 per share, and in separate transactions purchased 13,700 shares and sold 13,200 shares.
Borregaard ASA: The Board of Directors' dividend proposal to Borregaard's Annual General Meeting
2 February 2023: Borregaard ASA (“Borregaard”, OSE ticker: BRG)
Borregaard ASA: Key information related to the cash dividend
2 February 2023: Borregaard ASA («Borregaard», OSE ticker: BRG)
Borregaard ASA: EBITDA1 of NOK 364 million in the 4th quarter
Borregaard's operating revenues reached NOK 1,770 million (NOK 1,446 million)2 in the 4th quarter of 2022. EBITDA1 increased to NOK 364 million (NOK 263 million). BioMaterials and Fine Chemicals had s...
Borregaard ASA: Invitation to Q4 2022 announcement
26 January 2023: Borregaard ASA (”Borregaard”, OSE ticker: BRG)
Borregaard ASA: Share buy-back programme completed
Reference is made to the stock exchange notice of 4 November 2022 where Borregaard announced the intent to repurchase up to 200,000 of its outstanding common stock. The repurchase of shares will be co...